» Articles » PMID: 17312162

The Type I IFN Response to Infection with Mycobacterium Tuberculosis Requires ESX-1-mediated Secretion and Contributes to Pathogenesis

Overview
Journal J Immunol
Date 2007 Feb 22
PMID 17312162
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

The ESX-1 secretion system is a major determinant of Mycobacterium tuberculosis virulence, although the pathogenic mechanisms resulting from ESX-1-mediated transport remain unclear. By global transcriptional profiling of tissues from mice infected with either wild-type or ESX-1 mutant bacilli, we found that host genes controlled by ESX-1 in vivo are predominantly IFN regulated. ESX-1-mediated secretion is required for the production of host type I IFNs during infection in vivo and in macrophages in vitro. The macrophage signaling pathway leading to the production of type I IFN required the host kinase TANK-binding kinase 1 and occurs independently of TLR signaling. Importantly, the induction of type I IFNs during M. tuberculosis infection is a pathogenic mechanism as mice lacking the type I IFNR were more restrictive for bacterial growth in the spleen than wild-type mice, although growth in the lung was unaffected. We propose that the ESX-1 secretion system secretes effectors into the cytosol of infected macrophages, thereby triggering the type I IFN response for the manipulation of host immunity.

Citing Articles

In vivo regulation of the monocyte phenotype by Mycobacterium marinum and the ESX-1 type VII secretion system.

Munke K, Wulff L, Lienard J, Carlsson F, Agace W Sci Rep. 2025; 15(1):4545.

PMID: 39915532 PMC: 11802795. DOI: 10.1038/s41598-025-88212-z.


VPS18 contributes to phagosome membrane integrity in -infected macrophages.

Jani C, Jain N, Marsh A, Uchil P, Doan T, Hudspith M Sci Adv. 2025; 11(5):eadr6166.

PMID: 39888996 PMC: 11784855. DOI: 10.1126/sciadv.adr6166.


Frequently arising ESX-1-associated phase variants influence fitness in the presence of host and antibiotic pressures.

Luna M, Oluoch P, Miao J, Culviner P, Papavinasasundaram K, Jaecklein E mBio. 2025; 16(3):e0376224.

PMID: 39873486 PMC: 11898584. DOI: 10.1128/mbio.03762-24.


How macrophage heterogeneity affects tuberculosis disease and therapy.

Russell D, Simwela N, Mattila J, Flynn J, Mwandumba H, Pisu D Nat Rev Immunol. 2025; .

PMID: 39774813 DOI: 10.1038/s41577-024-01124-3.


Tax1bp1 enhances bacterial virulence and promotes inflammatory responses during infection of alveolar macrophages.

Chin J, Abeydeera N, Repasy T, Rivera-Lugo R, Mitchell G, Nguyen V bioRxiv. 2025; .

PMID: 39763950 PMC: 11702572. DOI: 10.1101/2024.12.16.628616.